Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-22-004877

10% owner sold 134,558 shares at an average $1.50 ($202,209)

From the SEC's structured data for this filing

Trades in this filing

New Enterprise Associates 14, L.P. · 10% owner

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-21 Sale : show line 1 in the form −11,622 $1.67 $19,389 3,428,537 D
2022-01-24 Sale : show line 2 in the form −19,984 $1.55 $31,017 3,408,553 D
2022-01-25 Sale : show line 3 in the form −102,952 $1.47 $151,803 3,305,601 D
Open-market sales · 134,558 sh · avg $1.50 · $202,209
Loading xslF345X03/doc4.xml…